-
公开(公告)号:DE19648793A1
公开(公告)日:1998-05-28
申请号:DE19648793
申请日:1996-11-26
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , MOELLER ACHIM DR , TREIBER HANS-JOERG DR
IPC: A61K31/16 , A61K31/166 , A61K31/18 , A61K31/4045 , A61K31/435 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/47 , A61P9/10 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/28 , A61P27/00 , A61P35/00 , A61P35/04 , A61P43/00 , C07C233/76 , C07C235/42 , C07C235/46 , C07C235/58 , C07C235/60 , C07C235/84 , C07C237/42 , C07C311/08 , C07C311/21 , C07C317/44 , C07C323/42 , C07C323/60 , C07D209/14 , C07D209/16 , C07D213/30 , C07D213/56 , C07D213/71 , C07D213/82 , C07D215/36 , C07C233/42 , C07C323/56 , C07C323/25 , C12N9/99
Abstract: The invention relates to compounds of the formula (I) in which R , R , R , X and n have the meaning given in the description. The compounds are suitable for combating diseases.
-
公开(公告)号:AT69953T
公开(公告)日:1991-12-15
申请号:AT88120960
申请日:1988-12-15
Applicant: BASF AG
Inventor: HERR DIETER DR , DOERPER THOMAS DR , DAUM LOTHAR DR , GEISS KARL-HEINZ DR , MOELLER ACHIM DR
IPC: C08B37/10 , A61K20060101 , A61K31/715 , A61P31/12 , A61K31/725
-
公开(公告)号:DE3839639A1
公开(公告)日:1990-05-31
申请号:DE3839639
申请日:1988-11-24
Applicant: BASF AG
Inventor: MOELLER ACHIM DR , KAPP ALEXANDER DR
Abstract: The use of TNF in the treatment of inflammatory skin diseases is described.
-
公开(公告)号:DE3744119A1
公开(公告)日:1989-07-06
申请号:DE3744119
申请日:1987-12-24
Applicant: BASF AG
Inventor: HERR DIETER DR , DOERPER THOMAS DR , DAUM LOTHAR DR , GEISS KARL-HEINZ DR , MOELLER ACHIM DR
IPC: C08B37/10 , A61K20060101 , A61K31/715 , A61P31/12
-
公开(公告)号:DE3620656A1
公开(公告)日:1987-12-23
申请号:DE3620656
申请日:1986-06-20
Applicant: BASF AG
Inventor: SCHOLLMEIER KLAUS DR , MOELLER ACHIM DR , KOERWER WOLFGANG DR , DOERPER THOMAS DR
-
公开(公告)号:DE19718251A1
公开(公告)日:1998-11-05
申请号:DE19718251
申请日:1997-04-30
Applicant: BASF AG
Inventor: AMMERMANN EBERHARD DR , BUTTERFIELD EARLE DR , LERCHL JENS DR , LORENZ GISELA DR , MOELLER ACHIM DR , RABE UDO DR , SCHMIDT RALF-MICHAEL DR , CONRAD UDO DR
IPC: A01H5/00 , C07K14/00 , C07K16/44 , C12N15/09 , C12N15/13 , C12N15/82 , C12P21/02 , A01H1/00 , C07K16/00
Abstract: The invention relates to a method for producing fungicide-tolerant plants by expressing a fungicide-binding antibody therein.
-
公开(公告)号:ES2052513T3
公开(公告)日:1994-07-16
申请号:ES87108847
申请日:1987-06-20
Applicant: BASF AG
-
公开(公告)号:DE3866686D1
公开(公告)日:1992-01-16
申请号:DE3866686
申请日:1988-12-15
Applicant: BASF AG
Inventor: HERR DIETER DR , DOERPER THOMAS DR , DAUM LOTHAR DR , GEISS KARL-HEINZ DR , MOELLER ACHIM DR
IPC: C08B37/10 , A61K20060101 , A61K31/715 , A61P31/12 , A61K31/725
Abstract: Polysulphated heparins (I) are used to prepare medicaments for prophylaxis and therapy of diseases caused by retroviruses. (I) have an S content of 13-15% and a molecular wt. of 2000-20,000 (esp. 2000-9000 for oral admin). They may be prepd. by converting heparin to the pyridinium salt and reacting this with ClSO3H in pyridine. The medicaments may be formulated for oral or parenteral admin., or as sprays. The daily dose is 10-1000 mg/kg oral or 0.1-10 mg/kg parenteral.
-
公开(公告)号:DE3925183A1
公开(公告)日:1991-02-07
申请号:DE3925183
申请日:1989-07-29
Applicant: BASF AG
Inventor: DOERPER THOMAS DR , HILLEN HEINZ DR , EMLING FRANZ DR , DAUM LOTHAR DR , MOELLER ACHIM DR
IPC: A61K38/00 , A61P29/00 , A61P31/04 , A61P37/06 , C07K14/47 , C07K14/52 , C07K14/525 , C07K19/00 , C12N1/21 , C12N5/24 , C12N15/09 , C12P21/02 , C12R1/19
Abstract: The invention relates to derivatives of the tumour necrosis factor (TNF) produced by joining partial sequences of the heavy leukokinine chain to the terminal amino of the mature human TNF. These proteins are suitable for use in drugs. A process for obtaining them is also described.
-
公开(公告)号:DE3843534A1
公开(公告)日:1990-07-12
申请号:DE3843534
申请日:1988-12-23
Applicant: BASF AG
Inventor: DAUM LOTHAR DR , DOERPER THOAMS DR , HILLEN HEINZ DR , MOELLER ACHIM DR , SCHOLLMEIER KLAUS DR , WALKER NIGEL DR , KEILHAUER GERHARD DR
IPC: A61K38/00 , C07K14/525 , C12N1/21 , C12N15/28
Abstract: Polypeptides derived from tumour necrosis factors (TNF) differ from natural TNF by the substitution and/or deletion of amino acids. These novel polypeptides are useful therapeutic agents.
-
-
-
-
-
-
-
-
-